$ORKA
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Healthcare
Sector
Biotechnology
Industry
Lawrence Otto Klein
CEO
28
Employees
$105.35
Current Price
$34.82M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 12 | $2,938,406.65 | 28,000 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 17 | $5,328,531.56 | 53,000 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 4 | 22 | $6,035,266.39 | 62,000 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 39 | $10,442,848.48 | 114,532 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 6 | 57 | $19,870,426.03 | 216,895 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated-$0.60
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated-$0.60
Actual-$0.63
Miss
Revenue
EstimatedN/A
ActualN/A
2 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: